Tom Shoemaker is a partner in the audit and assurance group at Crowe. He specializes in IPO offerings, secondary offerings, reverse mergers, SEC comment letters, and periodic SEC reporting requirements. Tom has more than 25 years of experience providing services related to life sciences working in the clinical stage through commercialization. He has a deep understanding of the technical accounting complexities associated with debt and equity financings, stock-based compensation and revenue recognition, and other topics.